Shares Outstanding Shares Outstanding n/a Close	20.37M
Shares Change (YoY) Shares Change (YoY) n/a Close	17.86%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	8.18%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	99.99%
Shares Floating Shares Floating n/a Close	18.22M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	2,294
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.54%

Short Selling Information

The latest short interest is 1.8M, so 8.83% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	1.8M
Short % of Shares Out Short % of Shares Out n/a Close	8.83%
Short % of Float Short % of Float n/a Close	8.85%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	7.09

Valuation Ratios

The PE ratio is -7.54 and the forward PE ratio is -3.89. Praxis Precision Medicines's PEG ratio is 0.17.

PE Ratio PE Ratio n/a Close	-7.54
Forward PE Forward PE n/a Close	-3.89
PS Ratio PS Ratio n/a Close	161.13
Forward PS Forward PS n/a Close	2
PB Ratio PB Ratio n/a Close	3.09
P/FCF Ratio P/FCF Ratio n/a Close	-10.46
PEG Ratio PEG Ratio n/a Close	0.17

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Praxis Precision Medicines.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.

Current Ratio Current Ratio n/a Close	10.77
Quick Ratio Quick Ratio n/a Close	10.77
Debt / Equity Debt / Equity n/a Close	0
Debt / EBITDA Debt / EBITDA n/a Close	-0.01
Debt / FCF Debt / FCF n/a Close	-0.01
Interest Coverage Interest Coverage n/a Close	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$73,732.76
Profits Per Employee Profits Per Employee n/a Close	$-1,576,025.86
Employee Count Employee Count n/a Close	116
Asset Turnover Asset Turnover n/a Close	0.02
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	n/a
Effective Tax Rate Effective Tax Rate n/a Close	0%

Stock Price Statistics

The stock price has increased by 13.75% in the last 52 weeks. The beta is 2.62, so Praxis Precision Medicines's price volatility has been higher than the market average.

Beta Beta n/a Close	2.62
52-Week Price Change 52-Week Price Change n/a Close	13.75%
50-Day Moving Average 50-Day Moving Average n/a Close	37.15
200-Day Moving Average 200-Day Moving Average n/a Close	58.45
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	63.67
Average Volume (20 Days) Average Volume (20 Days) n/a Close	425,487

Income Statement

In the last 12 months, Praxis Precision Medicines had revenue of 8.55M and earned -182.82M in profits. Earnings per share was -10.21.

Revenue Revenue n/a Close	8.55M
Gross Profit Gross Profit n/a Close	8.2M
Operating Income Operating Income n/a Close	-200.16M
Net Income Net Income n/a Close	-182.82M
EBITDA EBITDA n/a Close	-199.81M
EBIT EBIT n/a Close	-200.16M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-10.21

Full Income Statement

Balance Sheet

The company has 215.37M in cash and 1.37M in debt, giving a net cash position of 214M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	215.37M
Total Debt Total Debt n/a Close	1.37M
Net Cash Net Cash n/a Close	214M
Retained Earnings Retained Earnings n/a Close	-836.74M
Total Assets Total Assets n/a Close	478.74M
Working Capital Working Capital n/a Close	294.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -131.76M and capital expenditures 0, giving a free cash flow of -131.76M.

Operating Cash Flow Operating Cash Flow n/a Close	-131.76M
Capital Expenditures Capital Expenditures n/a Close	n/a
Free Cash Flow Free Cash Flow n/a Close	-131.76M
FCF Per Share FCF Per Share n/a Close	-7.36

Full Cash Flow Statement

Margins

Gross margin is 95.81%, with operating and profit margins of -2340.29% and -2137.48%.

Gross Margin Gross Margin n/a Close	95.81%
Operating Margin Operating Margin n/a Close	-2340.29%
Pretax Margin Pretax Margin n/a Close	-2137.48%
Profit Margin Profit Margin n/a Close	-2137.48%
EBITDA Margin EBITDA Margin n/a Close	-2336.1%
EBIT Margin EBIT Margin n/a Close	-2340.29%
FCF Margin FCF Margin n/a Close	-1540.48%

Dividends & Yields

PRAX does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for PRAX is $85, which is 91.7% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$85
Price Target Difference Price Target Difference n/a Close	91.7%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	10

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:15.

Last Split Date Last Split Date n/a Close	Nov 29, 2023
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:15

Scores

Altman Z-Score Altman Z-Score n/a Close	10.68
Piotroski F-Score Piotroski F-Score n/a Close	1